DEPUY ORTHOPAEDICS - search results

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

xermelo

serb sas - telotristat etiprat - carcinoid tumor; neuroendocrine tumors - drugi proizvodi prebavnega trakta in metabolizma - xermelo je indicirano za zdravljenje driska sindrom karcinoid v kombinaciji z somatostatina analogne (ssa) terapija pri odraslih, neustrezno nadzira prp terapijo.

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

gefitinib mylan

mylan pharmaceuticals limited - gefitinib - karcinom, pljučni pljuč - antineoplastic agents, protein kinase inhibitors - gefitinib mylan je označen kot monotherapy za zdravljenje odraslih bolnikov z lokalno napredno ali metastatskim non‑small cell lung cancer (nsclc) z aktiviranjem mutacije z egfr‑tk.

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

bevespi aerosphere

astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - pljučna bolezen, kronična obstruktivna bolezen - formoterol in glycopyrronium bromid - bevespi aerosphere je označen kot vzdrževanje bronchodilator zdravljenje za lajšanje simptomov pri odraslih bolnikih s kronično obstruktivno pljučno bolezen (kopb).

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

locametz

novartis europharm limited - gozetotide - radionuklidno slikanje - diagnostični radiofarmacevtiki - to zdravilo je samo za diagnostično uporabo. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

apretude

viiv healthcare b.v. - cabotegravir - okužbe z virusom hiv - antivirusi za sistemsko uporabo - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 in 5.